Health
PD-L1: A Therapeutic Target for Malignant Melanomas in Dogs – Technology Networks
Scientists have shown that PD-L1 is a potential anti-cancer therapy target for the treatment of metastasized oral malignant melanoma in dogs.
Scientists have shown that the biological molecule PD-L1 is a potential target for the treatment of metastasized oral malignant melanoma in dogs.
There are a number of cancers that affect dogs, but there are far fewer diagnosis and treatment options for these canine cancers. However, as dogs and humans are both mammals, it is likely that strategies and treatments for cancers in humans can be used for canine cancer, with minor modifications.
A team of scientists, including Associate Professor Satoru…
-
Noosa News20 hours agoWoman was watching keepers work when lion attacked, Darling Downs Zoo says
-
General23 hours agoDeveloper warns wind energy capacity may not be ready by WA coal deadline
-
Noosa News19 hours agoWorking for someone else made it hard to care for my daughter. So I quit
-
General23 hours agoDisloyal far-left breakaways are coming for Labor